NervGen Pharma
A medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
$130m
Enterprise valuation
$111m (Public information from Sep 2024)
Share price
$2.006 NGENF
Vancouver British Columbia (HQ)
Authorizing premium user...